Limited impact of real-world evidence in medical oncology: how can AI turn the tide

Real-world evidence (RWE), derived from real-world health data (RWD) generated during routine clinical practice, is increasingly recognized as a valuable complement to traditional clinical trial data in medical oncology. While randomized controlled trials remain the gold standard for evidence-based...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pellat, Anna (VerfasserIn) , Kather, Jakob Nikolas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 October 2025
In: European journal of cancer
Year: 2025, Jahrgang: 228, Pages: 1-3
ISSN:1879-0852
DOI:10.1016/j.ejca.2025.115714
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejca.2025.115714
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804925004976
Volltext
Verfasserangaben:Anna Pellat, Jakob Nikolas Kather

MARC

LEADER 00000naa a2200000 c 4500
001 1965060005
003 DE-627
005 20260312092143.0
007 cr uuu---uuuuu
008 260312s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2025.115714  |2 doi 
035 |a (DE-627)1965060005 
035 |a (DE-599)KXP1965060005 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pellat, Anna  |e VerfasserIn  |0 (DE-588)1392721210  |0 (DE-627)1965060625  |4 aut 
245 1 0 |a Limited impact of real-world evidence in medical oncology  |b how can AI turn the tide  |c Anna Pellat, Jakob Nikolas Kather 
264 1 |c 1 October 2025 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 15. August 2025, Artikelversion: 27. August 2025 
500 |a Gesehen am 12.03.2026 
520 |a Real-world evidence (RWE), derived from real-world health data (RWD) generated during routine clinical practice, is increasingly recognized as a valuable complement to traditional clinical trial data in medical oncology. While randomized controlled trials remain the gold standard for evidence-based medicine, they often face limitations due to rising costs, ethical constraints, and the inability to cover all treatment combinations and diverse patient populations. The current impact of RWE is limited by several challenges, including data inconsistency, quality issues, and burdensome data collection processes. Despite its role in specific areas like accelerating drug development in rare cancers, RWE has yet to achieve its full potential due to these limitations. Artificial intelligence (AI), particularly through natural language processing and large language models (LLMs), presents a transformative opportunity for RWE. AI technologies can streamline data collection, extraction, cleaning, and analysis, making the process more efficient and accurate. LLMs, for instance, can extract structured data from unstructured text and facilitate the integration of diverse data sources. This automation can significantly reduce the workload on clinicians and improve the consistency and reliability of RWD. These tools can address existing challenges and unlock the full potential of RWD, ultimately leading to improved patient outcomes and more robust oncology research. 
650 4 |a Artificial intelligence 
650 4 |a Large language models 
650 4 |a Real-world evidence 
700 1 |a Kather, Jakob Nikolas  |d 1989-  |e VerfasserIn  |0 (DE-588)1064064914  |0 (DE-627)812897587  |0 (DE-576)423589091  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 228(2025) vom: Okt., Artikel-ID 115714, Seite 1-3  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Limited impact of real-world evidence in medical oncology how can AI turn the tide 
773 1 8 |g volume:228  |g year:2025  |g month:10  |g elocationid:115714  |g pages:1-3  |g extent:3  |a Limited impact of real-world evidence in medical oncology how can AI turn the tide 
856 4 0 |u https://doi.org/10.1016/j.ejca.2025.115714  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0959804925004976  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260312 
993 |a Article 
994 |a 2025 
998 |g 1064064914  |a Kather, Jakob Nikolas  |m 1064064914:Kather, Jakob Nikolas  |d 910000  |d 910100  |e 910000PK1064064914  |e 910100PK1064064914  |k 0/910000/  |k 1/910000/910100/  |p 2  |y j 
999 |a KXP-PPN1965060005  |e 4933848920 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"3 S."}],"name":{"displayForm":["Anna Pellat, Jakob Nikolas Kather"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"1 October 2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1965060005","note":["Online verfügbar: 15. August 2025, Artikelversion: 27. August 2025","Gesehen am 12.03.2026"],"person":[{"given":"Anna","role":"aut","family":"Pellat","display":"Pellat, Anna"},{"role":"aut","given":"Jakob Nikolas","display":"Kather, Jakob Nikolas","family":"Kather"}],"language":["eng"],"title":[{"title":"Limited impact of real-world evidence in medical oncology","subtitle":"how can AI turn the tide","title_sort":"Limited impact of real-world evidence in medical oncology"}],"id":{"eki":["1965060005"],"doi":["10.1016/j.ejca.2025.115714"]},"relHost":[{"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266883400","pubHistory":["28.1992 -"],"titleAlt":[{"title":"EJC online"}],"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research"},{"role":"isb","display":"European School of Oncology"}],"id":{"zdb":["1468190-0"],"eki":["266883400"],"issn":["1879-0852"]},"language":["eng"],"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"part":{"pages":"1-3","volume":"228","text":"228(2025) vom: Okt., Artikel-ID 115714, Seite 1-3","year":"2025","extent":"3"},"origin":[{"publisher":"Elsevier ; Pergamon Press","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992","dateIssuedDisp":"1992-"}],"disp":"Limited impact of real-world evidence in medical oncology how can AI turn the tideEuropean journal of cancer"}]} 
SRT |a PELLATANNALIMITEDIMP1202